Literature DB >> 24081121

Reply to "On the mechanism and benefit of siRNA-mediated targeting of CD47 in cancer".

Yuhua Wang1, Zhenghong Xu, Leaf Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24081121      PMCID： PMC3808128          DOI： 10.1038/mt.2013.206

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  8 in total

1.  Enhanced phagocytosis of CD47-deficient red blood cells by splenic macrophages requires SHPS-1.

Authors:  Tomomi Ishikawa-Sekigami; Yoriaki Kaneko; Yasuyuki Saito; Yoji Murata; Hideki Okazawa; Hiroshi Ohnishi; Per-Arne Oldenborg; Yoshihisa Nojima; Takashi Matozaki
Journal:  Biochem Biophys Res Commun       Date:  2006-03-24       Impact factor: 3.575

2.  On the mechanism and benefit of siRNA-mediated targeting of CD47 in cancer.

Authors:  Xiwen Zhao; Hanke Matlung; Taco W Kuijpers; Timo K van den Berg
Journal:  Mol Ther       Date:  2013-10       Impact factor: 11.454

3.  Role of CD47 as a marker of self on red blood cells.

Authors:  P A Oldenborg; A Zheleznyak; Y F Fang; C F Lagenaur; H D Gresham; F P Lindberg
Journal:  Science       Date:  2000-06-16       Impact factor: 47.728

4.  Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia.

Authors:  Mattias Olsson; Pierre Bruhns; William A Frazier; Jeffrey V Ravetch; Per-Arne Oldenborg
Journal:  Blood       Date:  2005-01-21       Impact factor: 22.113

5.  CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction.

Authors:  Xi Wen Zhao; Ellen M van Beek; Karin Schornagel; Hans Van der Maaden; Michel Van Houdt; Marielle A Otten; Pascal Finetti; Marjolein Van Egmond; Takashi Matozaki; Georg Kraal; Daniel Birnbaum; Andrea van Elsas; Taco W Kuijpers; Francois Bertucci; Timo K van den Berg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

6.  Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.

Authors:  Yuhua Wang; Zhenghong Xu; Shutao Guo; Lu Zhang; Arati Sharma; Gavin P Robertson; Leaf Huang
Journal:  Mol Ther       Date:  2013-06-18       Impact factor: 11.454

7.  Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response.

Authors:  Diane Tseng; Jens-Peter Volkmer; Stephen B Willingham; Humberto Contreras-Trujillo; John W Fathman; Nathaniel B Fernhoff; Jun Seita; Matthew A Inlay; Kipp Weiskopf; Masanori Miyanishi; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

8.  Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.

Authors:  Kipp Weiskopf; Aaron M Ring; Chia Chi M Ho; Jens-Peter Volkmer; Aron M Levin; Anne Kathrin Volkmer; Engin Ozkan; Nathaniel B Fernhoff; Matt van de Rijn; Irving L Weissman; K Christopher Garcia
Journal:  Science       Date:  2013-05-30       Impact factor: 47.728
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.